MicroRNA‐18a modulates P53 expression by targeting IRF2 in gastric cancer patients. Issue 1 (January 2016)

• Record Type: Journal Article
• Authors: Chen, Yan‐Jie; Wu, Hao; Zhu, Ji‐Min; Li, Xiao‐Dan; Luo, Si‐Wei; Dong, Ling; Liu, Tao‐Tao; Shen, Xi‐Zhong
• Is Part Of: Journal of gastroenterology and hepatology. Volume 31:Issue 1(2016:Jan.)
• Page Start: 155
• Page End: 163
• Publication Date: 2016-01
• Subjects: biomarker -- gastric cancer -- IRF2 -- miR‐18a -- prognosis; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.13041
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: MicroRNA‐18a (miR‐18a) has been reported to be upregulated in gastric cancer (GC) tissues compared with normal gastric tissues. However, little is known about its prognostic value and biological roles. Methods: In this study, miR‐18a expression in gastric adenocarcinoma (GAC) tissues and adjacent non‐tumor tissues was validated by in situ hybridization, and the predictive values of miR‐18a were explored. The biological roles of miR‐18a and the underlying signal pathway were investigated in GC cell lines. Results: Overexpressed intra‐tumoral miR‐18a was associated with poor survival rate and was an independent prognostic factor for overall survival rate ( P < 0.001) in GC patients. Forced expression of miR‐18a remarkably enhanced cell proliferation, migration, and invasion in GC cells, while inhibition of miR‐18a caused the opposite effects. Further study showed that miR‐18a suppressed the expression of interferon regulatory factor 2 (IRF2) by directly binding to its 3′‐untranslated region. Moreover, miR‐18a expression levels are inversely correlated with IRF2 in human GC tissues. Western blot showed that forced expression of miR‐18a could not only downregulate the expression of IRF2, but also inhibit the expression of P53, suggesting that IRF2 might play as a tumor suppressor by regulating P53 signaling in GC. Conclusion: miR‐18a modulated P53 expression by directly targeting IRF2 and had a high predictive value for prognosis of GAC patients. These results may lead to identification of therapeutic candidates of GC.